semaglutide approval US FDA approves weight loss drug Wegovy to prevent cardiovascular events FDA Approves Oral Semaglutide as

A nationwide cohort study on diabetes severity and risk of Parkinson disease

Improvements in bloating, constipation patterns , and overall digestive comfort may correlate with broader immune function changes, though this connection has not been formally studied in clinical trials

Ozempic suits diabetic patients seeking moderate weight loss

In head-to-head comparisons, semaglutide and tirzepatide achieve the greatest glycemic efficacy, often normalizing blood sugar in a substantial fraction of patients, whereas older agents like exenatide and lixisenatide have somewhat lesser potency

reported a 77-year-old man who was found to have bilateral CBH and fourth and lateral ventricular hemorrhages following a T11S1 posterior instrumented fusion with an L2 pedicle subtraction osteotomy for kyphoscoliosis and ankylosing spondylitis [8]